Microwave-induced thermal sterilization- A review on history, technical progress, advantages and challenges as compared to the conventional methods

Publication date: March 2020Source: Trends in Food Science &Technology, Volume 97Author(s): Aswathi Soni, Jeremy Smith, Abby Thompson, Gale BrightwellAbstractMicrowave-assisted thermal sterilizsation (MATS) technology combines the energy from microwaves of long-wavelength (915 MHz) along with hot water immersion to sterilize food in polymeric packages. MATS is presumed to be a successful sterilization method to eliminate pathogens including bacterial spores, improve the shelf-life of food products while the nutritive qualities and flavours are not affected (within consumer acceptance). From the regulatory point of view, it is a thermal technology for pre-packaged commercial sterilization of homogeneous and nonhomogeneous foods as accepted by the Food and Drug Administration (FDA).Scope and approachThis review covers the technical progress, advantages and challenges associated with MATS technology with a comparison to conventional methods and its potential in the food industry. This comprehensive background study is worth considering while developing protocols and validation assays for MATS.Key findingsMATS is postulated to not only eliminate the edge-heating issues, but it also reduces the heat exposure time to minimize the effect on heat-sensitive components while achieving maximum microbial inactivation. MATS technology has promising potentials and has been expected to have comparable results if not better to retorting in sterilization while ensuring better sensory...
Source: Trends in Food Science and Technology - Category: Food Science Source Type: research

Related Links:

CONCLUSION: Extensive research have been carried out on various process for preparing Bortezomib and composition thereof. This type of dynamic research will clear the path for many generic players in the United States which lead in reduction of price of the composition and thereby enhancing global health care at cheaper prices. PMID: 32234004 [PubMed - as supplied by publisher]
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research
FDA has granted Emergency Use Authorization (EUA) to Battelle's CCDS Critical Care Decontamination System for processing up to 80,000 respirator masks per system each day. CCDS employs concentrated, vapor-phase hydrogen peroxide (VPHP) for decontamination. The system has been validated to decontaminate masks of SARS-CoV-2, the company reported. The masks are placed on shelves inside a container, and a portable, external VPHP system is hooked up to the outside of container. The system was first envisioned by Battelle as part of a study commissioned by FDA in 2015. That study involved determining the feasibility of N95 respi...
Source: MDDI - Category: Medical Devices Authors: Tags: Sterilization Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s): Jorge A Alfaro-Murillo, Marí L Ávila-Agüero, Meagan C Fitzpatrick, Caroline J Crystal, Luiza-Helena Falleiros-Arlant, Alison P Galvani
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s): Stephen W Russell, Brian T Garibaldi, Andrew Elder, Abraham Verghese
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s):
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s): Fathiah Zakham, Olli Vapalahti, Hilal A Lashual
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s): Renato D Lopes, Claudio Gimpelewicz, John J V McMurray
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s): Genichi Sugihara, Nori Takei
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: 4–10 April 2020Source: The Lancet, Volume 395, Issue 10230Author(s): Gorka Orive, Unax Lertxundi
Source: The Lancet - Category: General Medicine Source Type: research
More News: Food and Drug Administration (FDA) | Food Science | Nutrition | Science | Study